Vivos Inc. creates wholly owned India subsidiary for manufacturing and therapies

VIVOS INC

Board approved creation of Vivos Scientific India LLP on September 17, 2025.
Entity is wholly owned, aims to establish manufacturing center in India.
Objective includes expanding human therapies and commercialization in India.
Will generate additional human trial data to support FDA approval process.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.